Genix Pharmaceuticals Corp. News Releases

Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms

Tue, 07 Oct 2025 17:48:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") wishes to clarify an error in its news release dated September 04, 2025, regarding the Company's recently closed non-brokered private placement.The previous release incorrectly stated that the Units were issued at a price of $0.10 per Unit. The correct issue price was $0.05 per Unit.Accordingly, the Company issued 2,000,000 units (each, a "Unit") at a price...

Genix Pharmaceuticals Closes Private Placement

Thu, 04 Sep 2025 16:15:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") announces that it has closed its previously announced non-brokered private placement raising gross proceeds of $100,000. The Company has issued 2,000,000 units (each a "Unit") at a price of $0.10 per Unit. Each Unit consists of one common share of the Company (a "Share") and one transferable common share purchase warrant (a "Warrant"). Each Warrant...

Genix Announces TSX-V Approval of Warrant Amendments

Tue, 06 Feb 2024 13:29:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 6, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that pursuant to its news release of January 18, 2024, the TSX Venture Exchange has approved the Company's application to amend both the exercise price and the warrant accelerator terms, in addition to extending the expiry dates of 3,354,945 previously issued and outstanding warrants (the "Warrants").The current exercise price of...

Genix Announces Warrant Repricing and Seeks Extension

Thu, 18 Jan 2024 18:05:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an application to the TSX Venture Exchange (the "Exchange") to amend the exercise price, the warrant accelerator terms and extend the expiry date of 3,354,945 previously issued and outstanding warrants (the "Warrants").The Corporation is proposing to reduce the exercise price of the warrants from $0.30 per...

Genix Announces AGM Results

Fri, 26 May 2023 16:27:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") is pleased to report the results of the Annual General Meeting of shareholders held on May 18, 2023 (the "AGM"). Each of the director nominees proposed by management for election were elected to the Board of Directors: Sina Pirooz, Mahmoud Aziz, Kevin Bottomley, Jamie Lewin, and Paul Chow. In addition, the following resolutions presented below...